Comparative Effectiveness of Different Frequencies of Spinal Cord Stimulation for the Treatment of Patients with Failed Back Surgery Syndrome: Systematic Review and Network Meta-Analysis

不同频率脊髓刺激治疗腰椎手术失败综合征患者的疗效比较:系统评价和网络荟萃分析

阅读:1

Abstract

PURPOSE: Failed back surgery syndrome (FBSS) is a common and challenging complication after lumbar spine surgery, with around 30% of patients experiencing this condition post-surgery. Spinal cord stimulation (SCS) is a prevalent treatment for FBSS, yet there is a lack of systematic comparisons among different SCS frequencies. This first network meta-analysis (NMA) compared the effectiveness and superiority of different SCS frequencies for FBSS. MATERIAL AND METHODS: Adhering to PRISMA guidelines, we searched PubMed, Web of Science, Embase, and CENTRAL for RCTs. Bayesian random-effects network meta-analysis assessed outcomes including pain reduction, functional capacity, and health-related quality of life. RESULTS: This NMA (11 RCTs; n=2275) revealed efficacy variations among SCS modalities. Based on surface under the cumulative ranking (SUCRA) rankings, subperception SCS (500-1200 Hz) had the highest probability for global pain relief (SUCRA=64.0%) and ≥50% pain reduction (SUCRA=75.3%; P < 0.05 vs low-frequency SCS). High-frequency SCS (10 kHz) was associated with higher SUCRA values for back pain (99.7%; P < 0.05 vs comparators; consistency χ²=1.41, P = 0.703) and leg pain (93.2%; P < 0.05 vs low-frequency SCS), suggesting a potential advantage. For functional outcomes, high-frequency SCS correlated with better ODI scores (SUCRA=85.0%), while subperception SCS showed higher probability for improved EQ-5D metrics (SUCRA=80.3%). All networks satisfied transitivity assumptions without significant inconsistency (P > 0.05). CONCLUSION: This NMA suggests potential differential therapeutic profiles among SCS modalities for FBSS. HF-SCS (10 kHz) showed relatively higher SUCRA values for back pain (99.7%), leg pain (93.2%), and disability improvement (ODI 85.0%). Subperception SCS (500-1200 Hz) was associated with better probability for global pain relief (64.0%), ≥50% pain reduction (75.3%), and HRQoL outcomes (EQ-5D 80.3%). These findings warrant validation in head-to-head RCTs.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。